PPARG and leukemia: Data shown byYamakawa-Karakida et al. demonstrated that PPARγ activation by both troglitazone and15d-PGJ2 inhibits proliferation and induces apoptosis inpromyelocytic leukemia cells under serum-free conditions [147].